SCYNEXIS, Inc. (SCYX)

USD 1.09

(12.36%)

Total Debt Summary of SCYNEXIS, Inc.

  • SCYNEXIS, Inc.'s latest annual total debt in 2023 was 15.08 Million USD , down -68.97% from previous year.
  • SCYNEXIS, Inc.'s latest quarterly total debt in 2024 Q2 was 15.54 Million USD , up 2.03% from previous quarter.
  • SCYNEXIS, Inc. reported annual total debt of 48.59 Million USD in 2022, up 11.39% from previous year.
  • SCYNEXIS, Inc. reported annual total debt of 43.62 Million USD in 2021, up 119.87% from previous year.
  • SCYNEXIS, Inc. reported quarterly total debt of 15.54 Million USD for 2024 Q2, up 2.03% from previous quarter.
  • SCYNEXIS, Inc. reported quarterly total debt of 14.7 Million USD for 2023 Q2, down -70.12% from previous quarter.

Annual Total Debt Chart of SCYNEXIS, Inc. (2023 - 2012)

Created with Highcharts 11.1.0YearsTotal Debt2012201320142015201620172018201920202021202220230 USD10000000 USD20000000 USD30000000 USD40000000 USD50000000 USD60000000 USD

Historical Annual Total Debt of SCYNEXIS, Inc. (2023 - 2012)

Year Total Debt Total Debt Growth
2023 15.08 Million USD -68.97%
2022 48.59 Million USD 11.39%
2021 43.62 Million USD 119.87%
2020 19.84 Million USD 33.31%
2019 14.88 Million USD -1.31%
2018 15.08 Million USD 2.93%
2017 14.65 Million USD 2.81%
2016 14.25 Million USD 0.0%
2015 - USD 0.0%
2014 - USD -100.0%
2013 15 Million USD -43.28%
2012 26.44 Million USD 0.0%

Peer Total Debt Comparison of SCYNEXIS, Inc.

Name Total Debt Total Debt Difference
Intra-Cellular Therapies, Inc. 16.93 Million USD 10.969%
PainReform Ltd. 86 Thousand USD -17434.884%
Alvotech 1.07 Billion USD 98.598%
Collegium Pharmaceutical, Inc. 674.28 Million USD 97.764%
ANI Pharmaceuticals, Inc. 315.32 Million USD 95.218%
Aquestive Therapeutics, Inc. 98.82 Million USD 84.74%
Journey Medical Corporation 17.73 Million USD 14.946%
Dynavax Technologies Corporation 256.91 Million USD 94.13%
Esperion Therapeutics, Inc. 540.94 Million USD 97.212%
Bright Green Corporation 1.85 Million USD -714.35%
Pacira BioSciences, Inc. 586.04 Million USD 97.427%
Embecta Corp. 1.63 Billion USD 99.08%
Sunshine Biopharma, Inc. 657.7 Thousand USD -2192.821%
Sunshine Biopharma, Inc. 657.7 Thousand USD -2192.821%
Petros Pharmaceuticals, Inc. 8.27 Million USD -82.201%
Silver Spike Investment Corp. - USD -Infinity%
China SXT Pharmaceuticals, Inc. 2.64 Million USD -469.604%
Alpha Teknova, Inc. 30.45 Million USD 50.489%
Safety Shot Inc 1.54 Million USD -873.548%
Procaps Group, S.A. 285.93 Million USD 94.726%
Cosmos Health Inc. 12.42 Million USD -21.378%
Theratechnologies Inc. 58.96 Million USD 74.427%
Harrow Health, Inc. 190.5 Million USD 92.084%
Sonoma Pharmaceuticals, Inc. 608 Thousand USD -2380.263%
Biofrontera Inc. 5.39 Million USD -179.311%
DURECT Corporation 20.74 Million USD 27.311%
Supernus Pharmaceuticals, Inc. 41.52 Million USD 63.686%
Cronos Group Inc. 2.53 Million USD -493.715%
OptiNose, Inc. 131.74 Million USD 88.554%
Ironwood Pharmaceuticals, Inc. 715.53 Million USD 97.892%
Kala Pharmaceuticals, Inc. 36.32 Million USD 58.484%
RedHill Biopharma Ltd. 1.17 Million USD -1185.586%
Organogenesis Holdings Inc. 119.35 Million USD 87.365%
Guardion Health Sciences, Inc. - USD -Infinity%
Cumberland Pharmaceuticals Inc. 18.42 Million USD 18.17%
Radius Health, Inc. 365.31 Million USD 95.872%
Universe Pharmaceuticals INC 5.48 Million USD -175.059%
ProPhase Labs, Inc. 21.38 Million USD 29.467%
Phibro Animal Health Corporation 525.45 Million USD 97.13%
Procaps Group S.A. 285.93 Million USD 94.726%
TherapeuticsMD, Inc. 8 Million USD -88.382%
Viatris Inc. 18.12 Billion USD 99.917%
Rockwell Medical, Inc. 13.43 Million USD -12.211%
Aytu BioPharma, Inc. 15.12 Million USD 0.324%
SIGA Technologies, Inc. 1.46 Million USD -930.048%
Tilray Brands, Inc. 387.31 Million USD 96.107%
Lifecore Biomedical, Inc. 130.36 Million USD 88.432%
Shineco, Inc. 29.65 Million USD 49.151%
PetIQ, Inc. 468.3 Million USD 96.78%
Regencell Bioscience Holdings Limited 59.8 Thousand USD -25114.44%
Incannex Healthcare Limited 373 Thousand USD -3942.895%
Neurocrine Biosciences, Inc. 428.4 Million USD 96.48%
Alimera Sciences, Inc. 67.39 Million USD 77.626%
Assertio Holdings, Inc. 40.91 Million USD 63.14%
Shuttle Pharmaceuticals Holdings, Inc. 1.08 Million USD -1286.419%
Clever Leaves Holdings Inc. 2.08 Million USD -622.568%
Cyclo Therapeutics, Inc. 1.03 Million USD -1359.663%
Avadel Pharmaceuticals plc 35.38 Million USD 57.382%
Hempacco Co., Inc. 13.72 Million USD -9.876%
Talphera, Inc. - USD -Infinity%
Alvotech 1.07 Billion USD 98.598%
Eagle Pharmaceuticals, Inc. 62.46 Million USD 75.859%
Lantheus Holdings, Inc. 616.94 Million USD 97.556%
Currenc Group, Inc. 31.94 Million USD 52.792%
Kamada Ltd. 8.74 Million USD -72.363%
Indivior PLC 281.6 Million USD 94.645%
Evoke Pharma, Inc. 5 Million USD -201.6%
Flora Growth Corp. 3.67 Million USD -310.675%
Cyclo Therapeutics, Inc. 1.03 Million USD -1359.663%
Evolus, Inc. 126.54 Million USD 88.083%
HUTCHMED (China) Limited 86.13 Million USD 82.492%
Amphastar Pharmaceuticals, Inc. 623.64 Million USD 97.582%
Akanda Corp. 3.99 Million USD -277.114%